Sobhan Darou Co.

What Sobhan Darou Co. does

Sobhan Darou Co. (شرکت سبحان دارو) is an Iranian publicly listed pharmaceutical manufacturer (Tehran Stock Exchange ticker: دسبحان/Dasobhan) founded in 1976 with original technical know-how from Ciba Geigy (now Novartis). The company operates from a corporate headquarters in Tehran and a 100,000 square meter manufacturing facility in Rasht Industrial City, Gilan Province, holding 233 production licenses and ranked first in Iran by production volume. Sobhan Darou produces generic and branded medications across 12 therapeutic categories including neurology/psychiatry (its leading segment), cardiovascular, antibiotics, pain relief, gastrointestinal, anti-diabetic, allergy, and supplements, with GMP-certified solid and semi-solid dosage form production lines and ISO 9001-2015, ISO 10002-2014, and ISO 10004-2012 certifications.

The company's product portfolio includes over 28 named pharmaceutical products spanning CNS agents (Sermenta/Sertraline, Abilizol/Aripiprazole, Diazepam, Topiramate, Tegrazepin/Carbamazepine, Primidone, Alzantin/Memantine), cardiovascular drugs (Enalapril, Atorvastatin, Diltiazem, Dipyridamole, Atenolol), pain relief formulations (Diclotan ER, Diclofenac Gel, Acetadodin), and topical preparations. R&D focuses on extended-release formulations and novel delivery systems, particularly in CNS therapeutics. The company is a subsidiary of the Barakat Healthcare and Pharmaceutical Group, which is part of the state-affiliated Setad Ejraiye Farman Emam conglomerate.

Sobhan Darou distributes its products domestically through pharmaceutical wholesalers including Nik Fardaye Salim (Nafas) and Pakhsh Darougostaran Nokhbegan, with products reaching patients via retail pharmacies across Iran. Pricing is fully regulated by Iran's Food and Drug Organization. The company is developing export channels, with active negotiations initiated with Sudan for African market entry. Revenue is generated through one-time pharmaceutical product sales, with recent expansion into contract manufacturing (e.g., with Ramona Darou for supplements).

Name

Sobhan Darou Co.

Legal name

شرکت سبحان دارو (سهامی عام) / Sobhan Darou Pharmaceutical Company (Public Joint Stock Company)

Website

https://sobhandarou.com

Company type

Public

Founded year

1976

Operating status

Operating

Headcount range

251–500 employees

Short description

Sobhan Darou Co. is a publicly listed Iranian pharmaceutical manufacturer, ranked first nationally by production volume, producing generic and branded medications across 12 therapeutic categories with leadership in CNS/psychiatry, GMP-certified facilities, and nationwide distribution through Barakat Group.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Oral Solid Dose (OSD) Generics (HLAIABAD)

akta.pro secondary industries

Generic Hospital & Institutional Products (HLAIABAL), Allergy, Sinus & Respiratory (Non-Asthma) (HLAIADAC)

Keywords

• Generic pharmaceuticals
• Pharmaceutical manufacturing
• CNS medications
• Cardiovascular drugs
• Antibiotic production

Headquarters

HQ city

Tehran

HQ country

Iran

HQ region

Middle East

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: The company generates revenue through manufacturing and selling generic pharmaceutical products across 12 therapeutic categories including neurology/psychiatry, cardiovascular, antibiotics, pain relief, digestive, anti-diabetic, and supplements. Products are sold domestically through distribution networks and pharmacies.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Sobhan Darou manufactures and distributes generic pharmaceutical products across 12 therapeutic categories, including CNS/psychiatry, neurology, cardiovascular, antibiotics, pain relief, gastrointestinal, anti-diabetic, allergy/respiratory, and supplements. The company holds 233 production licenses and operates GMP-certified solid and semi-solid dosage form production lines at its Rasht manufacturing facility.

Product overview

Sobhan Darou Co. is an Iranian pharmaceutical company offering a diverse portfolio of generic and branded medications across 12 therapeutic categories. The product portfolio includes: CNS/Psychiatry products (Sermenta, Abilizol, Diazepam), Neurology medications (Topiramate, Tegrazepin, Primidone, Alzantin), Cardiovascular drugs (Enalapril, Dipyridamole, Diltiazem, Atorvastatin, Atenolol), Antibiotics (Zoviderm, Tetratopic), Pain relief medications (Methyl Salicylate Ointment, Diclotan ER, Diclotan, Diclofenac Gel, Acetadodin), Gastrointestinal products (Omeprazole), Renal/Urinary medications (Solifex), Corticosteroids (Betamethasone), Anti-diabetics (Metformin ER), Allergy/Respiratory (Loratadine), Supplements (Caffeine), and Other category products (Vitamin A D, Diltigel, Brimotop Gel). The company holds 233 production licenses and ranks first nationally by production volume, with particular leadership in CNS/psychiatry medications. The company operates as part of the Barakat Pharmaceutical Health Group and maintains GMP-certified solid and semi-solid dosage form production lines.

Differentiator

Problem solved

Functional benefit

Products and services

• Sermenta (سرmenta) Selective serotonin reuptake inhibitor (SSRI) antidepressant used for major depressive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder, obsessive-compulsive disorder, and post-traumatic stress disorder.
• Abilizol (ابیلیزول) Atypical antipsychotic (aripiprazole) used for treatment of schizophrenia in adults and children over 13 years, adjunctive treatment of manic episodes in bipolar I disorder, and adjunctive treatment in major depressive disorder.
• Diazepam (دیازپام) Benzodiazepine sedative used for short-term treatment of moderate to severe anxiety disorders, muscle spasms, cerebral palsy, and as adjunctive therapy for specific types of epilepsy.
• Topiramate (توپیرامات) Antiepileptic drug used as monotherapy or adjunctive therapy for partial and tonic-clonic epilepsy, and for migraine prevention in women.
• Tegrazepin (تگرازپین) Antiepileptic from carbamazepine class used for partial and tonic-clonic epilepsy, trigeminal neuralgia nerve pain, and adjunctive treatment in bipolar disorder.
• Primidone (پریمیدون) Barbiturate antiepileptic used as monotherapy or adjunctive therapy for grand mal, partial, and psychomotor epilepsy.
• Alzantin (آلزانتین) Glutamate antagonist (memantine) used for treatment of Alzheimer's disease in adults.
• Enalapril (انالاپریل) ACE inhibitor used for symptomatic heart failure, prevention of heart failure in asymptomatic patients with left ventricular dysfunction, and hypertension.
• Dipyridamole (دی‌پیریدامول) Platelet aggregation inhibitor used as adjunctive therapy for prevention of thromboembolic problems.
• Diltiazem (دیلتیازم) Calcium channel blocker used for hypertension treatment.
• Atorvastatin (آتورواستاتین) Statin cholesterol-lowering agent used for hypercholesterolemia.
• Atenolol (آتولول-سبحان) Selective beta-1 receptor blocker used for hypertension, chronic stable angina, and risk reduction in patients with myocardial infarction history.
• Zoviderm (زوویدرم) Topical antiviral cream containing acyclovir, a nucleoside analog used for herpes simplex virus infections on lips and genitals.
• Tetratopic (تتراتاپیک) Topical tetracycline antibiotic used for skin infections caused by certain strains of streptococcus, staphylococcus, and gram-negative bacteria.
• Diclotan ER (دیکوتان پیوسته‌رهش) Extended-release diclofenac sodium tablet used for control of inflammation and pain relief in acute musculoskeletal problems, trauma, sprains, dislocations, strains, and back pain.
• Diclotan (دیکلوتان) Enteric-coated diclofenac sodium tablet used for control of inflammation and pain in arthritis, acute musculoskeletal problems, tendinitis, tenosynovitis, bursitis, gout, and trauma.
• Diclofenac Gel (دیکلوفناک ژل) Topical NSAID gel for local relief of pain and inflammation caused by musculoskeletal problems.
• Acetadodin (استاکدین) Combined analgesic containing acetaminophen 300mg and codeine 20mg used for control of mild to moderate pain in headaches, muscle/joint problems, toothache, and dysmenorrhea.
• Methyl Salicylate Ointment (متیل سالیسیلات) Topical analgesic ointment for local relief of pain and inflammation caused by musculoskeletal problems and injuries.
• Omeprazole (امپرازول) Proton pump inhibitor in 20mg capsules used for reducing stomach acidity in prevention and treatment of gastric and duodenal ulcers, gastroesophageal reflux, and Zollinger-Ellison syndrome.
• Solifex (سولیفکس) Muscarinic receptor antagonist (solifenacin) in 5mg coated tablets used for neurogenic bladder or overactive bladder with symptoms of urge incontinence, urgency, and urinary frequency.
• Betamethasone (بتامتازون) Topical corticosteroid ointment used for skin inflammation and irritation from contact dermatitis, allergic dermatitis, seborrheic dermatitis, insect bites, psoriasis, lichen planus, and lupus.
• Metformin ER (متفورمین) Extended-release biguanide antidiabetic in 500 and 1000mg tablets used for blood sugar control in adults with type 2 diabetes.
• Loratadine (لوراتادین) Second-generation antihistamine in 10mg scored tablets used for allergic rhinitis and chronic idiopathic urticaria.
• Caffeine (کافئین) Supplement in 100 and 200mg capsules used to help relieve fatigue and drowsiness, improve muscle function in athletes, and relieve pain.
• Vitamin A D (ویتامین آ+د) Topical vitamin A and D ointment used as a skin protective and emollient for mild skin inflammation such as minor burns, heat rash, superficial cuts, abrasions, and dry skin from cold weather.
• Diltigel (دیلتیژل) Topical diltiazem gel, a calcium channel blocker used for anal fissure. Due to minimal systemic absorption, contraindications differ from oral diltiazem forms.
• Brimotop Gel (بریموتاپ) Topical brimonidine gel, an alpha-2 adrenergic agonist used for persistent erythema and redness of facial skin caused by rosacea.

Quantifiable outcome

• 233 production licenses held, making it one of the most diversified generic pharmaceutical manufacturers in Iran
• +1 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Eight partnerships are on record, tiered minor and core.

• Sudan RepresentativeminorGTM or Marketing Partner · 1 January 1404Negotiations initiated with a Sudanese representative for pharmaceutical export cooperation. The discussions focus on creating conditions for trade exchange and expanding into international markets in Africa.
• Nik Fardaye Salim - Nafas Distribution (پخش نفس)minorChannel Partner/ Reseller/ Distributor · 1 January 1404Joint meeting focused on developing bilateral cooperation in marketing, distribution, and supply chain areas.
• Pakhsh Darougostaran Nokhbegan (پخش داروگستر نخبگان)minorChannel Partner/ Reseller/ Distributor · 1 January 1404Joint meeting to expand bilateral cooperation and enhance coordination in pharmaceutical distribution and supply chain operations across Iran.
• Ramona Darou (رامونا دارو)minorStrategic or Co-development Partner · 1 January 1404CEO of Ramona Darou visited Sobhan Darou's facilities to explore contract manufacturing opportunities for supplement products. Potential annual revenue estimated at 30 billion Tomans.
• Madaxsa (مداکسا)minorGTM or Marketing Partner · 1 January 1404Joint meeting to strengthen bilateral cooperation in marketing and market development. Both parties emphasized synergy for market growth.
• Dr. Gharib Innovation Center (مرکز نوآوری دکتر قریب)minorStrategic or Co-development Partner · 1 January 1404Researchers from the innovation center visited Sobhan Darou to explore cooperation in developing innovative pharmaceutical and nutritional supplement products. Focus on technology localization.
• Barkat Healthcare and Pharmaceutical Group (گروه سلامت و دارویی برکت)coreStrategic or Co-development PartnerSobhan Darou is part of the Barkat Group's pharmaceutical value chain. The company participates in joint projects for new product development and attends coordination meetings with other group subsidiaries to advance shared objectives.
• Shafa Pharm Group (گروه صنایع شفا فارمد)minorStrategic or Co-development PartnerCEO of Shafa Pharm Group visited Rasht factory to discuss production trends, development plans, and future cooperation opportunities between group companies.

Scale indicators4 records

Recent moves11 records

Expansion highlights5 records

Direct peers

• Darou Pakhsh Pharma: One of Iran's largest pharmaceutical manufacturers, producing generic medications across multiple therapeutic categories for the domestic market. Directly comparable as a major Iranian generic pharma producer with similar portfolio breadth and B2B distribution to pharmacies and hospitals.
• Iran Darou: Iranian generic pharmaceutical manufacturer with a broad portfolio across multiple therapeutic categories. The Sobhan Darou CEO previously served as CEO and board member of Iran Darou, indicating deep familiarity and direct competitive overlap.
• Aburaihan Pharmaceutical Company: Iranian manufacturer of generic pharmaceuticals with focus on antibiotics and specialty categories. Directly comparable as a domestic Iranian generic producer; the Sobhan Darou CEO previously served as Production and Research Deputy there.
• Shafa Pharmed / Shafa Pharma Group: Iranian pharmaceutical manufacturer and part of a broader pharma group. Peer within the same Barakat-affiliated ecosystem and confirmed strategic cooperation partner for production and development activities.
• Caspian Pharmaceutical Company: Iranian generic pharmaceutical manufacturer serving the domestic healthcare market. Comparable peer in the same regulatory environment; the Sobhan Darou CEO previously served as a board member.
• Hakim Pharmaceutical Company: One of Iran's largest state-affiliated pharmaceutical manufacturers with diversified generic portfolio. Comparable as a major Iranian generic pharma with similar distribution scale and broad therapeutic coverage.

Regional players

• Julphar (Gulf Pharmaceutical Industries): Leading UAE-based generic pharmaceutical manufacturer serving MENA markets. Comparable as a regional generic pharma player of similar scale; serves as a benchmark for cross-border MENA pharmaceutical expansion.
• SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances): Saudi-listed pharmaceutical manufacturer producing generics across multiple therapeutic categories. Comparable as a large MENA-region generic pharma with similar diversification and B2B institutional sales motion.
• EIPICO (Egyptian International Pharmaceutical Industries Company): Egypt's largest generic pharmaceutical manufacturer, serving MENA and African markets. Comparable in terms of MENA regional positioning, scale of generic portfolio, and exposure to regulated domestic pricing.

Broad incumbents

• Cipla Limited: Major Indian-headquartered global generic pharmaceutical manufacturer with broad therapeutic coverage and emerging-market focus. Comparable as a global-scale generic manufacturer exporting to emerging markets including Iran and MENA.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/sobhan-darou-co.

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles18 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sobhan Darou Co.